Literature DB >> 1976147

Comparison of carbon-dioxide-enriched, oxygen-enriched, and normal air in treatment of acute mountain sickness.

P Bärtsch1, R W Baumgartner, U Waber, M Maggiorini, O Oelz.   

Abstract

Twenty mountaineers with acute mountain sickness (AMS) at an altitude of 4559 m were randomly allocated to treatment with oxygen-enriched (33% oxygen), carbon-dioxide-enriched (3% carbon dioxide), or normal compressed air. Treatment with oxygen significantly improved the arterial partial pressure of oxygen (PaO2), relieved symptoms of AMS, and reduced cerebral blood flow as estimated by transcranial doppler ultrasound examination of the median cerebral artery. The only significant effect of carbon dioxide was increased ventilation resulting in a slight rise in PaO2. Thus, in contrast to previous uncontrolled trials, this study does not support the usefulness of carbon dioxide treatment in AMS.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1976147     DOI: 10.1016/0140-6736(90)93240-p

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  9 in total

1.  Postural instability at a simulated altitude of 5,000 m before and after an expedition to Mt. Cho-Oyu (8,201 m).

Authors:  Masako Hoshikawa; Shiori Hashimoto; Takashi Kawahara; Rika Ide
Journal:  Eur J Appl Physiol       Date:  2010-06-13       Impact factor: 3.078

2.  Acute Mountain Sickness, High Altitude Cerebral Oedema, High Altitude Pulmonary Oedema: The Current Concepts.

Authors:  S R Mehta; A Chawla; A S Kashyap
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Simulated descent v dexamethasone in treatment of acute mountain sickness: a randomised trial.

Authors:  H R Keller; M Maggiorini; P Bärtsch; O Oelz
Journal:  BMJ       Date:  1995-05-13

4.  Treatment of acute mountain sickness by simulated descent: a randomised controlled trial.

Authors:  P Bärtsch; B Merki; D Hofstetter; M Maggiorini; B Kayser; O Oelz
Journal:  BMJ       Date:  1993-04-24

5.  Non-invasive positive pressure ventilation during sleep at 3800 m: Relationship to acute mountain sickness and sleeping oxyhaemoglobin saturation.

Authors:  Pamela L Johnson; Daniel A Popa; G Kim Prisk; Natalie Edwards; Colin E Sullivan
Journal:  Respirology       Date:  2009-12-27       Impact factor: 6.424

6.  Ophthalmodynamometry for ICP prediction and pilot test on Mt. Everest.

Authors:  Henry W Querfurth; Philip Lieberman; Steve Arms; Steve Mundell; Michael Bennett; Craig van Horne
Journal:  BMC Neurol       Date:  2010-11-01       Impact factor: 2.474

Review 7.  Interventions for treating acute high altitude illness.

Authors:  Daniel Simancas-Racines; Ingrid Arevalo-Rodriguez; Dimelza Osorio; Juan Va Franco; Yihan Xu; Ricardo Hidalgo
Journal:  Cochrane Database Syst Rev       Date:  2018-06-30

8.  Supplemental CO2 improves oxygen saturation, oxygen tension, and cerebral oxygenation in acutely hypoxic healthy subjects.

Authors:  Jan Stepanek; Ryan A Dunn; Gaurav N Pradhan; Michael J Cevette
Journal:  Physiol Rep       Date:  2020-07

9.  Different Placebos, Different Mechanisms, Different Outcomes: Lessons for Clinical Trials.

Authors:  Fabrizio Benedetti; Sara Dogue
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.